Universität zu Köln

Journal Article

Bobylev, Ilja, Peters, Dominik, Vyas, Maulik ORCID: 0000-0003-2996-4682, Barham, Mohammed, Klein, Ines, von Strandmann, Elke Pogge, Neiss, Wolfram F. and Lehmann, Helmar C. (2017). Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity. Neurotox. Res., 32 (4). S. 555 - 563. NEW YORK: SPRINGER. ISSN 1476-3524

Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, von Strandmann, Elke Pogge and Koehl, Ulrike (2018). Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset (vol 8, 1100, 2017). Front. Immunol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael ORCID: 0000-0001-5318-9044, von Strandmann, Elke Pogge and Koehl, Ulrike (2017). Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset. Front. Immunol., 8. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Vyas, Maulik ORCID: 0000-0003-2996-4682, Schneider, Ann-Charlott, Shatnyeva, Olga, Reiners, Katrin S., Tawadros, Samir, Kloess, Stephan, Koehl, Ulrike, Hallek, Michael, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2016). Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia. OncoImmunology, 5 (9). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Thesis

Vyas, Maulik (2016). Development of novel trispecific immunoligands (triplebodies) to retarget natural killer cells against chronic lymphocytic leukemia. PhD thesis, Universität zu Köln.